Deerfield, IL - Baxter International is now recalling from the market all remaining lots and doses of its heparin sodium multidose and single-dose vials for injection and its heparin lock flush ...

Accordingly, the FDA and Baxter decided not to recall all Baxter heparin vial products at that time. The FDA has now concluded that there is sufficient capacity on the part of other suppliers that ...

CHICAGO (Reuters) - Baxter International Inc on Monday said it has temporarily stopped making the blood-thinner heparin in multi-dose vials after four patients who took the drug died and hundreds of ...

The U.S. Food and Drug Administration announced that Baxter Healthcare Corp. has temporarily stopped manufacturing multiple-dose vials of the injectable blood-thinning drug heparin due to reports of ...

NDC NUMBERS 0641-2440-45, 0641-2440-41, 0641-2450-45 and 0641-2450-41; LOTS: 107054, 117085, 047056, 097081, 107024, 107064, 107066, 107074, 107111 DEERFIELD, Ill ...

NEW YORK, May 17 (Reuters) - Baxter International Inc shares fell 3 percent on Monday after its partner Halozyme Therapeutics Inc voluntarily recalled certain lots of their fluid-absorption drug due ...

Baxter Healthcare Corporation announced a voluntary recall of its remaining batch of heparin sodium injection multi-dose, single-dose vials and HEP-LOCK heparin flush products on Thursday, according ...

Hepatitis C outbreaks could have been avoided if drug manufacturers Baxter Healthcare Services and Teva Parenteral Medicine had sold smaller vials of propofol to healthcare facilities, argued a ...

First San Diego’s Cadence Pharmaceuticals (NASDAQ: CADX), and now, Halozyme Therapeutics (NASDAQ: HALO), have encountered troubles resulting from contaminated biomedical products coming from their ...